Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need
In today’s healthcare environment, where we see increasingly complex stakeholder needs and decreased direct access to HCPs and payers, the use of digital marketing activities pres
